Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- CheckyesterdayChange DetectedAdded related topics to the page: Type 2 diabetes and MedlinePlus Genetics. This aligns the page with the study's subject and improves navigation to related information.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check15 days agoChange DetectedA new revision note (v3.4.3) was added, and several related topics including Type 2 diabetes, MedlinePlus Genetics, and the previous revision reference (v3.4.2) were removed.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded related topics MedlinePlus Genetics and Type 2 diabetes for additional context, without altering the study's core information.SummaryDifference0.1%

- Check30 days agoChange DetectedRemoved 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics' from the related topics section. This alters the visible topic signals and may affect discoverability for users seeking information on type 2 diabetes and related genetics resources.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.